RevolutionEHR announces launch of revMarket

Article

RevolutionEHR announced the launch of revMarket, a cloud-based resource designed for optometrists, during a press conference at SECO on Thursday.

 

 

Atlanta, GA-RevolutionEHR announced the launch of revMarket, a cloud-based resource designed for optometrists, during a press conference at SECO on Thursday.

RevMarket will offer mobile apps, e-prescribing, electronic claims processing, and patient communications, among other services through secure web-service connections.

In related news, the company announced it has added 4 optometrists to its team of advisors. Kelly Kerksick, OD, will serve as a senior adviser on eyecare professional relations. Jason Miller, OD, MBA, will serve as an adviser on practice success. Brett Paepke, OD, will serve as an adviser on Stage 1 Meaningful Use support. Optometry Times Editorial Advisory Board member Mike Rothschild, OD, will serve as an adviser on early stage success. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.